Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph E Hagemeyer

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Current Pharmaceutical Design|January 21, 2011
Targeting the platelet integrin GPIIb/IIIaChristoph E Hagemeyer, Karlheinz Peter
Journal of Visualized Experiments : Jove|July 14, 2015
Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery VesselThomas Bonnard, Christoph E Hagemeyer
Seminars in Thrombosis and Hemostasis|March 7, 2007
Single-chain antibodies as new antithrombotic drugsChristoph E Hagemeyer, Meike Schwarz, Karlheinz Peter
Trends in Cardiovascular Medicine|August 15, 2012
Enzymatic antibody tagging: toward a universal biocompatible targeting toolHang T Ta, Karlheinz Peter, Christoph E Hagemeyer
Trends in Cardiovascular Medicine|December 18, 2020
Molecular imaging of atrial myopathy: Towards early AF detection and non-invasive disease managementMartin Ezeani, Christoph E Hagemeyer, Sean Lal, et al.
Frontiers in Cardiovascular Medicine|October 18, 2019
Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic OpportunitiesAkshita Rana, Erik Westein, Be'eri Niego, et al.
Nature Nanotechnology|December 19, 2022
The potential impact of nanomedicine on COVID-19-induced thrombosisPeije Russell, Lars Esser, Christoph E Hagemeyer, et al.
Journal of Thrombosis and Haemostasis : JTH|October 12, 2025
Thrombolytic drugs for ischemic stroke: historical perspective, state of play, and future developmentsBamlaku Enawgaw Walie, Christoph E Hagemeyer, Rong Xu, et al.
Research and Practice in Thrombosis and Haemostasis|July 25, 2022
A novel ex vivo approach for measuring plasminogen activation upon established plasma clotsJason S Palazzolo, Robert L Medcalf, Christoph E Hagemeyer, et al.
Current Atherosclerosis Reports|July 19, 2018
Psammomys obesus: a Natural Diet-Controlled Model for Diabetes and Cardiovascular DiseasesRajneesh Chaudhary, Ken R Walder, Christoph E Hagemeyer, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Current Pharmaceutical Design|January 21, 2011
Targeting the platelet integrin GPIIb/IIIaChristoph E Hagemeyer, Karlheinz Peter
Journal of Visualized Experiments : Jove|July 14, 2015
Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery VesselThomas Bonnard, Christoph E Hagemeyer
Seminars in Thrombosis and Hemostasis|March 7, 2007
Single-chain antibodies as new antithrombotic drugsChristoph E Hagemeyer, Meike Schwarz, Karlheinz Peter
Trends in Cardiovascular Medicine|August 15, 2012
Enzymatic antibody tagging: toward a universal biocompatible targeting toolHang T Ta, Karlheinz Peter, Christoph E Hagemeyer
Trends in Cardiovascular Medicine|December 18, 2020
Molecular imaging of atrial myopathy: Towards early AF detection and non-invasive disease managementMartin Ezeani, Christoph E Hagemeyer, Sean Lal, et al.
Frontiers in Cardiovascular Medicine|October 18, 2019
Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic OpportunitiesAkshita Rana, Erik Westein, Be'eri Niego, et al.
Nature Nanotechnology|December 19, 2022
The potential impact of nanomedicine on COVID-19-induced thrombosisPeije Russell, Lars Esser, Christoph E Hagemeyer, et al.
Journal of Thrombosis and Haemostasis : JTH|October 12, 2025
Thrombolytic drugs for ischemic stroke: historical perspective, state of play, and future developmentsBamlaku Enawgaw Walie, Christoph E Hagemeyer, Rong Xu, et al.
Research and Practice in Thrombosis and Haemostasis|July 25, 2022
A novel ex vivo approach for measuring plasminogen activation upon established plasma clotsJason S Palazzolo, Robert L Medcalf, Christoph E Hagemeyer, et al.
Current Atherosclerosis Reports|July 19, 2018
Psammomys obesus: a Natural Diet-Controlled Model for Diabetes and Cardiovascular DiseasesRajneesh Chaudhary, Ken R Walder, Christoph E Hagemeyer, et al.
Pageof 9